SG Americas Securities
AZN icon

SG Americas Securities’s AstraZeneca AZN Stock Holding History

SG Americas Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,000
Closed -$224K – 3477
2017
Q2 		$224K Buy
+40,000
New +$2.61M ﹤0.01% 2340

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

SG Americas Securities's AZN Position: Q1 2026 in Review

SG Americas Securities reduced its AstraZeneca (AZN) stake by 94% in Q1 2026, selling an estimated $22.9M and leaving 8,013 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

SG Americas Securities first reported a position in AZN in Q4 2016 and has held it in 34 quarters since. The position peaked at $23.3M in Q4 2025. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • SG Americas Securities held 8,013 shares of AstraZeneca worth $1.58M as of Q1 2026.
  • SG Americas Securities sold 118,724 AstraZeneca shares in Q1 2026, an estimated $22.9M.
  • AstraZeneca made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1506 holding.
  • SG Americas Securities first reported a position in AstraZeneca in Q4 2016 and has held it in 34 quarters since.
  • SG Americas Securities's AstraZeneca position peaked at $23.3M in Q4 2025.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.